Gut microbiome metabolic pathways (null)

The **gut microbiome metabolic pathways** encompass the sum of biochemical reactions carried out by the diverse microbial community residing in the human gastrointestinal tract. These pathways biotransform dietary components, endogenous substrates, bile acids, vitamins, and xenobiotics, thereby influencing nutrient extraction, energy metabolism, hormone release, immune function, and systemic metabolic homeostasis[1][3][7]. Disturbances in microbial metabolism are implicated in diseases such as metabolic syndrome, diabetes, obesity, and neurodegenerative disorders, making the gut microbiome a system-level therapeutic target. Drugs and dietary interventions aim to restore or modulate the function and composition of these pathways, often via manipulation of specific metabolite profiles, microbial taxa, or microbial enzymatic activities[1][2][4][6].\nThe “gut microbiome/metabolic pathways” is not a single molecule, receptor, enzyme, or transporter, but a multi-component ecosystem/system-level entity targeted therapeutically through various modalities. Thus, it falls outside traditional molecular drug targets but is highly relevant in modern pharmacology and systems medicine[1][2][3][4][5][6][7][8][9].

Other names

Gut microbiomeGut microbiota metabolic pathwaysIntestinal microbiome metabolismHuman gut microbial metabolic pathways

Alteration of microbial community composition and/or metabolic activity; Inhibition or modulation of specific microbial enzymes (e.g., bile salt hydrolase, BSH); Modulation of host-microbial co-metabolism (e.g., bile acid pathways, hormone induction); Production or inhibition of microbial metabolites that impact host physiology; Induction of gut hormone release.